Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gynevac lactobacillus vaccine in bacterial vaginosis (randomized double-blind study)
2013-002918-12Phase 3Terminated
- Sponsor
- AMVAC Chemical
- Start
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gynevac in bacterial vaginosis (BV) (2 arms), sponsored by AMVAC Chemical. Primary endpoint: Change in Nugent score in vaginal smear. Started Aug 2013; status: terminated.
02
Drugs
gynevac
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on 2013-002918-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002918-12.